SNGX
Soligenix Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.85M
P/E Ratio
—
EPS
$-2.14
Beta
1.94
52W High
$6.23
52W Low
$1.00
50-Day MA
$1.18
200-Day MA
$1.66
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
12.32
PEG Ratio
-1.52
About Soligenix Inc.
Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. The company is headquartered in Princeton, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-11.84M |
| Operating Margin | 0.00% |
| Return on Equity | -235.50% |
| Return on Assets | -81.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.77 |
| Price-to-Book | 2.16 |
| Price-to-Sales (TTM) | 4.00 |
| EV/Revenue | 1.872 |
| EV/EBITDA | -0.12 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $10.31M |
| Float | $9.76M |
| % Insiders | 0.15% |
| % Institutions | 9.49% |
Historical Volatility
HV 10-Day
53.53%
HV 20-Day
41.94%
HV 30-Day
40.68%
HV 60-Day
51.79%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($15.00 target)
1
BuyData last updated: 4/9/2026